• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后住院期间死亡风险评分的精确性和准确性:当前时代的研究。

Precision and accuracy of risk scores for in-hospital death after percutaneous coronary intervention in the current era.

机构信息

Division of Cardiology, Cardiac Catheterization Laboratory, NY Methodist Hospital, Brooklyn, New York 11215, USA.

出版信息

Catheter Cardiovasc Interv. 2010 Feb 1;75(2):153-7. doi: 10.1002/ccd.22352.

DOI:10.1002/ccd.22352
PMID:20095010
Abstract

BACKGROUND

Various risk assessment scores were proposed in the last decade for prediction of in-hospital mortality in patients undergoing percutaneous coronary intervention (PCI). We sought to apply two validated scores, the Mayo Clinic Risk Score (MCRS) and the New York Risk Score (NYRS) to a contemporary cohort treated at a single institution and to simplify the NYRS, such that the parameters used in both scores are similar.

METHODS AND RESULTS

Patients undergoing PCI in 2005-2007 were included. MCRS and NYRS were calculated for each patient. A simplified NYRS, similar to MCRS, was constructed by deleting two variables (gender and left main coronary stenosis). Model discrimination was assessed by the C statistic and goodness-of-fit (calibration) was measured with the Hosmer-Lemeshow test. There were 3,165 procedures. The in-hospital mortality was 0.56% (95% CI 0.31-0.83%). Mean MCRS was 2.7 +/- 2.4 (predicted mortality 0.3%). The C-statistic for MCRS was 0.82 (0.71-0.94) and the model was well calibrated (P = 0.79). Mean NYRS was 5.1 +/- 3.3, (predicted mortality 0.23%). The C-statistic for NYRS was 0.83 (0.74-0.95), not different from MCRS (P = 0.62) and the model was well calibrated (P = 0.29). The mean simplified NYRS was 4.6 +/- 3.1 among survivors and 10.9 +/- 5.8 among those who died, P < 0.001. The score had a C-statistic of 0.83 (0.71-0.95), not different from MCRS (P = 0.84) or NYRS (P = 0.27) and was well calibrated (P = 0.71).

CONCLUSION

PCI risk scores utilizing easily collected variables are useful in discriminating risk and predicting death. NYRS might be simplified by removing the gender and left main coronary stenosis variables from its algorithm.

摘要

背景

在过去的十年中,提出了各种风险评估评分来预测接受经皮冠状动脉介入治疗(PCI)的患者的住院死亡率。我们试图将两个经过验证的评分,即梅奥诊所风险评分(MCRS)和纽约风险评分(NYRS)应用于单一机构治疗的当代队列,并简化 NYRS,使得两个评分中使用的参数相似。

方法和结果

纳入了 2005-2007 年接受 PCI 的患者。为每位患者计算了 MCRS 和 NYRS。通过删除两个变量(性别和左主干冠状动脉狭窄),构建了与 MCRS 相似的简化 NYRS。通过 C 统计量评估模型区分度,通过 Hosmer-Lemeshow 检验评估拟合优度(校准)。共有 3165 例手术。住院死亡率为 0.56%(95%CI 0.31-0.83%)。平均 MCRS 为 2.7+/-2.4(预测死亡率 0.3%)。MCRS 的 C 统计量为 0.82(0.71-0.94),模型校准良好(P=0.79)。NYRS 的平均值为 5.1+/-3.3,预测死亡率为 0.23%。NYRS 的 C 统计量为 0.83(0.74-0.95),与 MCRS 无差异(P=0.62),模型校准良好(P=0.29)。幸存者的简化 NYRS 平均为 4.6+/-3.1,死亡者为 10.9+/-5.8,P<0.001。该评分的 C 统计量为 0.83(0.71-0.95),与 MCRS(P=0.84)或 NYRS(P=0.27)无差异,且校准良好(P=0.71)。

结论

利用易于收集的变量的 PCI 风险评分有助于区分风险和预测死亡。可以通过从其算法中删除性别和左主干冠状动脉狭窄变量来简化 NYRS。

相似文献

1
Precision and accuracy of risk scores for in-hospital death after percutaneous coronary intervention in the current era.经皮冠状动脉介入治疗后住院期间死亡风险评分的精确性和准确性:当前时代的研究。
Catheter Cardiovasc Interv. 2010 Feb 1;75(2):153-7. doi: 10.1002/ccd.22352.
2
The Mayo Clinic Risk Score predicts in-hospital mortality following primary angioplasty.梅奥诊所风险评分可预测初次血管成形术后的院内死亡率。
J Invasive Cardiol. 2005 Oct;17(10):522-6.
3
Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery.经皮冠状动脉介入治疗的梅奥诊所风险评分可预测接受冠状动脉旁路移植术患者的住院死亡率。
Circulation. 2008 Jan 22;117(3):356-62. doi: 10.1161/CIRCULATIONAHA.107.711523. Epub 2008 Jan 2.
4
Predicted and observed in-hospital mortality after left main coronary artery stenting in 204 patients.204例患者左主干冠状动脉支架置入术后的预测和观察到的院内死亡率。
Cardiol J. 2008;15(3):268-76.
5
Validation of the Mayo clinic risk score for in-hospital mortality after percutaneous coronary interventions using the national cardiovascular data registry.使用国家心血管数据注册中心验证梅奥诊所经皮冠状动脉介入治疗住院死亡率风险评分。
Circ Cardiovasc Interv. 2008 Aug;1(1):36-44. doi: 10.1161/CIRCINTERVENTIONS.107.755991.
6
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada.加拿大急性冠状动脉综合征患者住院死亡率的全球急性冠状动脉事件注册研究(GRACE)风险评分的验证
Am Heart J. 2009 Sep;158(3):392-9. doi: 10.1016/j.ahj.2009.06.010.
7
Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.纽约州经皮冠状动脉介入治疗患者的血管疾病负担和住院结局。
Circ Cardiovasc Interv. 2009 Aug;2(4):317-22. doi: 10.1161/CIRCINTERVENTIONS.108.847459.108.847459. Epub 2009 Jul 22.
8
The Toronto score for in-hospital mortality after percutaneous coronary interventions.经皮冠状动脉介入治疗后院内死亡率的多伦多评分
Am Heart J. 2009 Jan;157(1):156-63. doi: 10.1016/j.ahj.2008.08.026.
9
Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.与经皮冠状动脉介入治疗相比,冠状动脉旁路移植术患者的临床特征和早期死亡率:来自澳大利亚和新西兰心脏与胸外科医师协会(ASCTS)和墨尔本介入治疗组(MIG)登记处的见解。
Heart Lung Circ. 2009 Jun;18(3):184-90. doi: 10.1016/j.hlc.2008.10.005. Epub 2009 Mar 5.
10
Serious renal dysfunction after percutaneous coronary interventions can be predicted.经皮冠状动脉介入治疗后严重肾功能不全是可以预测的。
Am Heart J. 2008 Feb;155(2):260-6. doi: 10.1016/j.ahj.2007.10.007. Epub 2007 Nov 26.